Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended March 31, 2007, for HealthSouth Corporation (referred to as Encompass Health Corp in the request metadata, but identified as HealthSouth in the filing). The company is a major provider of inpatient rehabilitation services in the United States. During this period, HealthSouth executed a strategic repositioning to become a "pure-play" post-acute care provider. Consequently, the company reclassified its surgery centers, outpatient, and diagnostic divisions as discontinued operations and "held for sale," reducing its reportable segments from five to one (inpatient rehabilitation).
Key Financial Metrics
| Metric | Q1 2007 | Q1 2006 |
|---|---|---|
| Net Operating Revenues | $448.6 million | $441.6 million |
| Net Loss | $(56.6) million | $(435.1) million |
| Loss from Continuing Operations | $(29.2) million | $(432.8) million |
| Loss from Discontinued Operations | $(27.4) million | $(2.3) million |
| Adjusted Consolidated EBITDA | $68.7 million | $87.0 million |
| Net Cash Used in Operating Activities | $(5.8) million | $(73.1) million |
| Total Long-Term Debt | $3.3 billion | $3.4 billion (approx.) |
| Cash and Cash Equivalents | $26.2 million | $116.8 million |
Operating Margins: Total operating expenses were $410.4 million, representing 91.5% of net operating revenues, an improvement from 97.6% in the prior year period.
Material Changes vs. Prior Period
- Significant Loss Reduction: The Net Loss improved dramatically from $435.1 million in Q1 2006 to $56.6 million in Q1 2007. This improvement is primarily due to the absence of a $361.1 million "Loss on early extinguishment of debt" recorded in Q1 2006 during the company's recapitalization.
- Revenue Growth: Net operating revenues increased 1.6% to $448.6 million, driven by regulatory pricing changes effective October 2006 and a higher patient case mix index, despite flat inpatient volumes.
- Expense Management: Professional fees (accounting, tax, and legal) decreased 55.1% to $21.8 million, reflecting lower costs for financial reconstruction compared to the prior year. Conversely, Salaries and benefits increased 5.3% due to merit increases and higher costs for contract labor.
- Settlement Adjustments: The company recorded a $12.2 million credit (reduction in expense) related to government and class action settlements, primarily due to a reduction in the liability for securities litigation based on stock and warrant valuations.
- Discontinued Operations: The loss from discontinued operations increased to $27.4 million (from $2.3 million) largely due to a $32.7 million impairment charge in the diagnostic division as it was written down to fair value pending sale.
Guidance, Outlook, and Risks
Strategic Outlook: Management expects to deleverage the company using proceeds from the divestiture of its outpatient division (closed May 1, 2007, for ~$245 million), surgery centers (agreed to sell for ~$920 million), and diagnostic division (agreed to sell for ~$47.5 million). The company anticipates recording gains on these disposals in the second and third quarters of 2007.
Operational Challenges:
- 75% Rule Compliance: Medicare comprises 69% of revenues. The company faces volume volatility as facilities must meet stricter patient mix thresholds (increasing from 60% to 65% for many facilities in late 2007), which may cause volume declines in Q4 2007.
- Leverage: The company remains highly leveraged with approximately $3.3 billion in long-term debt. A significant downturn in operating earnings could jeopardize debt service obligations.
- Settlement Obligations: The company has significant near-term cash obligations, including $65.3 million remaining for the Medicare Program Settlement and $50.0 million for the SEC Settlement, due throughout the remainder of 2007.
Controls and Procedures: Management concluded that disclosure controls and procedures were ineffective as of March 31, 2007, due to a material weakness in internal controls over accounting for income taxes that persisted from the prior year.
Investor Verification Checklist
- Divestiture Closing: Verify the closing status and final proceeds of the surgery centers and diagnostic division sales, as these are critical to the deleveraging plan.
- Debt Covenants: Monitor compliance with the Credit Agreement's leverage and interest coverage ratios, given the high debt load and reliance on divestiture proceeds.
- 75% Rule Impact: Track patient mix compliance rates in Q3 and Q4 2007 to assess the anticipated volume decline and its effect on revenue.
- Settlement Payments: Confirm timely payment of the remaining Medicare and SEC settlement balances to avoid default or penalties.
- Internal Controls: Review subsequent filings for remediation of the material weakness regarding income tax accounting.